| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/28/2001 | EP1086120A1 Method for preparing virus-safe pharmaceutical compositions |
| 03/28/2001 | EP1086118A1 Vitamin b 12? derivatives and methods for their preparation |
| 03/28/2001 | EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085940A1 Method and apparatus for forming an encapsulated product matrix |
| 03/28/2001 | EP1085914A1 Plaster containing an active agent |
| 03/28/2001 | EP1085907A1 Solution comprising prostaglandins and benzyl alcohol |
| 03/28/2001 | EP1085901A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders |
| 03/28/2001 | EP1085883A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases |
| 03/28/2001 | EP1085877A1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 03/28/2001 | EP1085860A1 Formulations for the treatment of gastro-oesophageal reflux |
| 03/28/2001 | EP1085858A2 Transdermal therapeutic system for the administration of candesartan |
| 03/28/2001 | EP1085857A2 Cationic amphiphile micellar complexes |
| 03/28/2001 | EP1085856A2 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 03/28/2001 | EP1085855A1 Enhanced intra vaginal devices |
| 03/28/2001 | EP1085821A1 Use of 'nanofood' in foodstuff final products for humans and animals |
| 03/28/2001 | EP1085811A1 Broad specificity dna damage endonuclease |
| 03/28/2001 | EP0928189A4 Delivery of biologically active material in a liposomal formulation for administration into the mouth |
| 03/28/2001 | EP0921796B1 Tetrahydrolipstatin containing compositions |
| 03/28/2001 | EP0909166B1 Process for making a medicated chewing gum with a pleasant taste containing an inclusion complex |
| 03/28/2001 | EP0742714B1 Liquid pharmaceutical compositions comprising thyroid hormones |
| 03/28/2001 | EP0732922B1 Transdermal delivery device |
| 03/28/2001 | EP0721330B1 Pharmaceutical composition |
| 03/28/2001 | EP0719097B1 Novel dietetic phospholipid compositions and use thereof as a dietary supplement |
| 03/28/2001 | CN1289256A Absorbable microparticles |
| 03/28/2001 | CN1289255A Process for making absorbable microparticles |
| 03/28/2001 | CN1289251A synergistic mixtures of natural products |
| 03/28/2001 | CN1289250A Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 03/28/2001 | CN1288747A Composite medicine containing dihydromyricetrin |
| 03/28/2001 | CN1288746A Chinese medicine for mastopathy and its preparation |
| 03/28/2001 | CN1288741A Scald treating ointment resulting in no scar |
| 03/28/2001 | CN1288740A Preparation of rheumatism-eliminating and pain-relieving plaster |
| 03/28/2001 | CN1288735A Slow-releasing concentrated common perilla seed oil tablet and its preparation |
| 03/28/2001 | CN1288734A Fast-acting composite spray for cold and its preparation |
| 03/28/2001 | CN1288733A Compound preparation containing medicinal active bacteria and its preparation |
| 03/28/2001 | CN1288732A Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process |
| 03/28/2001 | CN1288731A Slow-releasing concentrated fish oil tablet and its preparation |
| 03/28/2001 | CN1288730A Slight-purgitive composition |
| 03/28/2001 | CN1288729A Freeze dried lentinan holoside powder injecta and its preparation |
| 03/28/2001 | CN1288728A High-molecular block copolymer-medicine compound preparation |
| 03/28/2001 | CN1288724A Qingkailing granule preparing process |
| 03/28/2001 | CN1288723A Nanometer-size realgar and its preparation |
| 03/28/2001 | CN1288722A Tear-gland specific emulsion for local application to eye tissue |
| 03/28/2001 | CN1288721A Gel composition and use thereof in cosmetic compositions and the like |
| 03/28/2001 | CN1063666C Oil-state fine medicinal powder preparation for treating carbuncle, sore and preparation method thereof |
| 03/28/2001 | CN1063664C Chinese medicine for treating gastrosis |
| 03/28/2001 | CN1063659C Chinese plaster for curing liver diseases and its preparation method |
| 03/28/2001 | CN1063641C Chinese medicinal preparation for treating toothache |
| 03/28/2001 | CN1063640C Use of phoenix-tail fern in medicine for treating nephrosis |
| 03/28/2001 | CN1063639C Powder medicine for setting broken bone and traditional Chinese dray plastic material containing it |
| 03/28/2001 | CN1063630C Surface-modified anticancer nanopartiles |
| 03/28/2001 | CN1063629C Bioerodible controlled-release medicine delivery system |
| 03/27/2001 | US6207718 Stability |
| 03/27/2001 | US6207717 Entrapment of vitamins with an elastomeric silicone polyether |
| 03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
| 03/27/2001 | US6207696 Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine |
| 03/27/2001 | US6207682 Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-piperidinecarboxylic acid |
| 03/27/2001 | US6207661 Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207638 For enhancing and extending post meal satiety by stimulating cholecystokinin levels in a calorically efficient manner for reducing weight, comprising protein consisting of casein, whey and soy, glycomacropeptide, long chain fatty acids, fibers |
| 03/27/2001 | US6207596 Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| 03/27/2001 | US6207456 Nucleic acid delivery vehicle |
| 03/27/2001 | US6207199 Process for making a particulate support matrix for making a rapidly dissolving dosage form |
| 03/27/2001 | US6207198 Omeprazole core comressed together with inert nuclei coated with a polymeric intermediatel layer overcoated with an enteric layer; stabilization |
| 03/27/2001 | US6207197 Microsphere comprising a drug-containing inner core, water insoluble polymeric rate controlling layer, and a bioadhesive outer layer of cationic polymer; treatment of helicobacter pylori |
| 03/27/2001 | US6207195 Sodium 4-phenylbutyrate in solid nanosphere formed by coacervation of a polycation, i.e., a protein and a polyanion, i.e., a nucleic acid; treatment of cystic fibrosis |
| 03/27/2001 | US6207193 Transdermal drug delivery system |
| 03/27/2001 | US6207192 Prolongation of chemical activity of flavorants and therapeutics with cetyl pyridinium chloride |
| 03/27/2001 | US6207191 Time-release capsule including a fluid permeable, drug-containing inner chamber having its opening plugged with a viscoelastic polymer which slides out of the way to release the drug when the interior fluid pressure increases in situ |
| 03/27/2001 | US6207190 Synergistic mixture to reduce ocular pressure and improve vascular health comprising folic acid, a magnesium salt, alpha-tocopherol, ascorbate and alpha-lipoic acid |
| 03/27/2001 | US6207189 Granulation of plant extract in the presence of steam at atmospheric pressure for a period of less than one second, drying in air, consolidation and encapsulation to form tablet |
| 03/27/2001 | US6207188 Omeprazole sodium salt |
| 03/27/2001 | US6207185 Method for inducing a systemic immune response to an HIV antigen |
| 03/27/2001 | US6207184 Hydrophilic adhesive masses |
| 03/27/2001 | US6207183 Transdermal administering |
| 03/27/2001 | US6207182 Adhesive patch for lithium controlled release |
| 03/27/2001 | US6207181 Transdermal therapy |
| 03/27/2001 | US6207180 Intravesical drug delivery |
| 03/27/2001 | US6207179 Mixture of edible oil, thickener, nematocide or parasiticide and cestocidal agent |
| 03/27/2001 | US6207178 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
| 03/27/2001 | US6207173 Lysine derivatives containing an Nε-alkoxy or Nε-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions |
| 03/27/2001 | US6207172 Liquids; mixture of water, polyethylene glycol, polyvinylpyrrolidone, buffer and drug |
| 03/27/2001 | US6207145 Therapeutic applications of high dose interferon |
| 03/27/2001 | US6207133 Anti-tumoral therapy agent containing a contrast agent |
| 03/27/2001 | US6206920 Composition and method for forming biodegradable implants in situ and uses of these implants |
| 03/27/2001 | US6206914 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/27/2001 | US6206297 Apparatus and method for manufacturing a gasdrop |
| 03/27/2001 | CA2321334A1 Composition and method for producing lubricating, germicide foam |
| 03/27/2001 | CA2277722C Water dispersible tablets |
| 03/27/2001 | CA2214399C Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
| 03/27/2001 | CA2148822C Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
| 03/27/2001 | CA2140347C Injection and injection kit containing omeprazole and its analogs |
| 03/27/2001 | CA2123118C Anhydrous topical compositions which dry rapidly on contact |
| 03/27/2001 | CA2075058C Novel vehicle gas mixtures and their use in medical preparations |
| 03/27/2001 | CA2072623C Bioadhesive composition and patch |
| 03/27/2001 | CA2046845C Sustained-release tablet |
| 03/27/2001 | CA2044170C Breathable backing |
| 03/27/2001 | CA2035492C Liquid lavage/ventilation of the pulmonary system |
| 03/24/2001 | CA2317977A1 Pellets |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |